L. Pabst

机构：Inserm, Regenerative NanoMedicine, Hôpitaux Universitaires de Strasbourg, Université de Strasbourg · ORCID：0000-0001-5668-4905

发表论文 23 篇 · 总被引 340 次 · h-index 6

代表论文

• Molecular Mechanism of EGFR-TKI Resistance in EGFR-Mutated Non-Small Cell Lung Cancer: Application to Biological Diagnostic and Monitoring (2021 · Cancers · 被引 101)
• Direct Targeting KRAS Mutation in Non-Small Cell Lung Cancer: Focus on Resistance (2022 · Cancers · 被引 95)
• Do proton pump inhibitors alter the response to immune checkpoint inhibitors in cancer patients? A meta-analysis (2023 · Frontiers in Immunology · 被引 69)
• Prognostic and Predictive Biomarkers in the Era of Immunotherapy for Lung Cancer (2023 · International Journal of Molecular Sciences · 被引 36)
• Persistent taxane‐induced neuropathy in elderly patients treated for localized breast cancer (2020 · The Breast Journal · 被引 21)
• Central nervous system complications of immune checkpoint inhibitors: A comprehensive review (2024 · Critical Reviews in Oncology/Hematology · 被引 16)